Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases

被引：82

作者：

Gardoni, Fabrizio ^{[1
]}

Bellone, Camilla ^{[2
]}

机构：

[1] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy

[2] Univ Lausanne, Dept Fundamental Neurosci, CH-1005 Lausanne, Switzerland

来源：

FRONTIERS IN CELLULAR NEUROSCIENCE | 2015年 / 9卷

关键词：

Dopamine; NMDA receptor; AMPA receptors; Addiction; Parkinson disease; Huntington disease; LONG-TERM POTENTIATION; EVOKED SYNAPTIC PLASTICITY; RECEPTOR-MEDIATED EXCITOTOXICITY; STRIATAL PROJECTION NEURONS; TRANSGENIC MOUSE MODEL; GLUR1 AMPA RECEPTOR; NMDA RECEPTOR; PREFRONTAL CORTEX; D-2; RECEPTOR; D1;

D O I：

10.3389/fncel.2015.00025

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Dopamine (DA) plays a major role in motor and cognitive functions as well as in reward processing by regulating glutamatergic inputs. In particular in the striatum the release of DA rapidly influences synaptic transmission modulating both AMPA and NMDA receptors. Several neurodegenerative and neuropsychiatric disorders, including Parkinson, Huntington and addiction related diseases, manifest a dysregulation of glutamate and DA signaling. Here, we will focus our attention on the mechanisms underlying the modulation of the glutamatergic transmission by DA in stnatal circuits.

引用

页数：11

共 50 条

[41] NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum
Schotanus, Sietske M.
Chergui, Karima
JOURNAL OF NEUROCHEMISTRY, 2008, 106 (04) : 1758 - 1765
[42] M4 mAChR-Mediated Modulation of Glutamatergic Transmission at Corticostriatal Synapses
Pancani, Tristano
Bolarinwa, Caroline
Smith, Yoland
Lindsley, Craig W.
Conn, P. Jeffrey
Xiang, Zixiu
ACS CHEMICAL NEUROSCIENCE, 2014, 5 (04): : 318 - 324
[43] Conventional and Novel Pharmacological Approaches to Treat Dopamine-Related Disorders: Focus on Parkinson's Disease and Schizophrenia
de la Mora, Miguel Perez
Hernandez-Mondragon, Carlos
Crespo-Ramierz, Minerva
Rejon-Orantes, Jose
Borroto-Escuela, Dasiel O.
Fuxe, Kjell
NEUROSCIENCE, 2020, 439 : 301 - 318
[44] Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease
Sgambato-Faure, Veronique
Cenci, Maria Angela
PROGRESS IN NEUROBIOLOGY, 2012, 96 (01) : 69 - 86
[45] Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission
Tozzi, Alessandro
Tscherter, Anne
Belcastro, Vincenzo
Tantucci, Michela
Costa, Cinzia
Picconi, Barbara
Centonze, Diego
CalabreSi, Paolo
Borsini, Franco
NEUROPHARMACOLOGY, 2007, 53 (06) : 783 - 789
[46] Modulation of GABAergic and glutamatergic transmission by ethanol in the developing neocortex: An in vitro test of the excessive inhibition hypothesis of fetal alcohol spectrum disorder
Sanderson, Jennifer L.
Partridge, L. Donald
Valenzuela, C. Fernando
NEUROPHARMACOLOGY, 2009, 56 (02) : 541 - 555
[47] Orphanin FQ nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis
Murphy, NP
Maidment, NT
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (01) : 179 - 186
[48] Disruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex
Li, Yan-Chun
Yang, Sha-Sha
Gao, Wen-Jun
NEUROPHARMACOLOGY, 2016, 108 : 403 - 414
[49] Presynaptic and Postsynaptic Modulation of Glutamatergic Synaptic Transmission by Activation of α1- and β-Adrenoceptors in Layer V Pyramidal Neurons of Rat Cerebral Cortex
Kobayashi, Masayuki
Kojima, Masao
Koyanagi, Yuko
Adachi, Kazunori
Imamura, Kazuyuki
Koshikawa, Noriaki
SYNAPSE, 2009, 63 (04) : 269 - 281
[50] Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases
Perez-Olives, Catalina
Rivas-Santisteban, Rafael
Lillo, Jaume
Navarro, Gemma
Franco, Rafael
CANNABINOIDS AND NEUROPSYCHIATRIC DISORDERS, 2021, 1264 : 81 - 92

← 1 2 3 4 5 →